🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

20 recruiting trials

for Muscular Dystrophy, Facioscapulohumeral

Safety and Preliminary Efficacy of ULSC in Facioscapulohumeral Muscular Dystrophy (FSHD) NCT07086521Phase 11 site📍 Palo Alto Restem, LLC. · Tests: ULSC, Placebo Amino Acids and Exercise in FSHD NCT07543016NA1 site📍 Voghera University of Pavia · Tests: Essential Amino Acids Supplementation intervention, Exercise, Diet, Placebo Control Motor Outcomes to Validate Evaluations in Pediatric FSHD (MOVE Peds) NCT06847282n/a7 sites📍 Palo Alto📍 Iowa City📍 Kansas City University of Kansas Medical Center Clenbuterol to Target DUX4 in FSHD NCT06721299Phase 13 sites📍 Kansas City📍 Rochester📍 Seattle Jeffrey Statland · Tests: Clenbuterol Gait Analysis Parameter and Upper Limb Evaluation in Adult Patients With Neurological or Metabolic Pathology NCT07136844NA1 site📍 Liège Centre Hospitalier Universitaire de Liege · Tests: Syde, Dynamometric measurements of muscle strength, The 6-minute walk test (6MWT), The 10-meter test (10MWT), The 4 sta… Biomarker Development for Muscular Dystrophies NCT05019625n/a5 sites📍 Boston📍 Boston📍 Boston Massachusetts General Hospital A Study to Evaluate Del-brax (Also Referred to as AOC 1020) in Participants With FSHD NCT07038200Phase 346 sites📍 Orange📍 Palo Alto📍 Denver Avidity Biosciences, Inc. · Tests: AOC-1020, Placebo An 18-month Prospective Natural History Study to Gain Insight Into FSHD2 Pathophysiology and Disease Progression NCT06079567NA9 sites📍 Leuven📍 Nice📍 Marseille Centre Hospitalier Universitaire de Nice · Tests: Validation of new COMs for FSHD2 patients Personalized Training for People With Rare Neuromuscular Disorders NCT06708468NA5 sites📍 Bergen📍 Molde📍 Namsos Oslo University Hospital · Tests: Exercise, Usual Care Phase 2 Study Evaluating Apitegromab for the Treatment of FSHD NCT07435129Phase 21 site📍 Austin Scholar Rock, Inc. · Tests: Apitegromab, Placebo Assessments in Patients With Muscular Pathology and in Control Subjects : The ActiLiège Next Study NCT05982119NA8 sites📍 Liège📍 Prague📍 Cairo Centre Hospitalier Universitaire de Liege · Tests: ActiMyo/Syde Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy Registry NCT00082108n/a1 site📍 Rochester University of Rochester BetterLife FSHD: A Patient-driven Health and Research Platform NCT07409142n/a1 site📍 Randolph FSHD Society · Tests: Observational Walking ANalysis Interest in Persons wiTh facioscapulohumEral Muscular Dystrophies NCT06600308NA1 site📍 Dijon Centre Hospitalier Universitaire Dijon · Tests: Walk tests, ecological (real-life) assessment of walking ability The United Kingdom Facioscapulohumeral Muscular Dystrophy Patient Registry NCT04001582n/a1 site📍 Newcastle upon Tyne Newcastle University · Tests: Patient Registry A Registered Cohort Study on FSHD1 NCT04369209n/a1 site📍 Fuzhou Ning Wang, MD., PhD. A Trial to Assess Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of SFL-0821 in Adults With FSHD NCT07798609Phase 1, Phase 26 sites📍 Concord📍 Liverpool📍 Brisbane Soufflé Therapeutics, Inc. · Tests: SFL-0821 for injection, Placebo Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease NCT07478172NA1 site📍 Columbia University of Missouri-Columbia · Tests: Whole-body Electrical Muscle Stimulation Exercise Ten Year Follow-up in FSHD: the FOCUS 3 Study NCT06911190n/a1 site📍 Nijmegen Radboud University Medical Center Magnetic Resonance Imaging and Ultrasound Comparison With Load Evaluation NCT06227182n/a1 site📍 Nijmegen Radboud University Medical Center · Tests: Muscle ultrasound with surface electromyography and dynamometry, MRI scan
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy